Research Library
Research Peptides: Studies, Compounds & Lab Tools
A curated, source-linked library covering the research peptides we track most closely. Every page below summarizes the current peer-reviewed evidence and regulatory status, and links back to primary sources so you can verify it yourself. For laboratory research use only.
Latest Updates
At its July 23–24, 2026 meeting, the FDA’s Pharmacy Compounding Advisory Committee voted to recommend BPC-157, TB-500, KPV and MOTS-c for the Section 503A bulks list. The votes are non-binding and are not FDA approval.
Read the FDA meeting page → Compound · UpdatedOur BPC-157 overview now covers the committee’s 8–6 recommendation, the latest 2026 preclinical studies, and why “recommended for compounding” is not the same as FDA approval.
Read the updated overview → Guide · New StudyA July 2026 rat Achilles-tendon study found TB-500 drove a significant biomechanical gain — but combining it with BPC-157 added no benefit over either alone. See what that means for the Wolverine Stack.
Read the guide → Review · Sports Medicine, 2026An April 2026 narrative review weighs BPC-157, TB-500, CJC-1295, ipamorelin and GHK-Cu, contrasting animal-model repair data with the current scarcity of rigorous human safety evidence.
Read the review on PubMed →Compound Overviews
A synthetic pentadecapeptide studied for decades in animal tissue-repair models. What the research proposes, and where the FDA status stands.
Read the overview → CompoundA synthetic fragment of thymosin beta-4 examined largely in wound-healing and dermal research. The evidence base and current regulatory picture.
Read the overview →Guides & Combinations
Research Materials & Peptides
Body-protection compound studied for tendon and soft-tissue repair. For research use only.
View material → PeptideActin-regulating peptide studied for cell migration and recovery. For research use only.
View material → StackCombined BPC-157 + TB-500 blend for soft-tissue recovery research. For research use only.
View material → StackCJC-1295 + Ipamorelin (5 mg each) for GH-axis research. For research use only.
View material →All content in this library is provided for educational and laboratory-research purposes only. It does not constitute medical advice, nor an offer to sell any drug or compounded product. The peptides discussed are not approved by the FDA for human use.